FR2521007B1 - Matiere intermediaire pour inophorese et solution de contact pour le traitement des syndromes douloureux chroniques - Google Patents

Matiere intermediaire pour inophorese et solution de contact pour le traitement des syndromes douloureux chroniques

Info

Publication number
FR2521007B1
FR2521007B1 FR8301852A FR8301852A FR2521007B1 FR 2521007 B1 FR2521007 B1 FR 2521007B1 FR 8301852 A FR8301852 A FR 8301852A FR 8301852 A FR8301852 A FR 8301852A FR 2521007 B1 FR2521007 B1 FR 2521007B1
Authority
FR
France
Prior art keywords
inophoresis
treatment
chronic pain
intermediate material
pain syndromes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8301852A
Other languages
English (en)
Other versions
FR2521007A1 (fr
Inventor
Bertalan Csillik
Erzsebet Knyihar
Attila Szucs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of FR2521007A1 publication Critical patent/FR2521007A1/fr
Application granted granted Critical
Publication of FR2521007B1 publication Critical patent/FR2521007B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR8301852A 1982-02-09 1983-02-07 Matiere intermediaire pour inophorese et solution de contact pour le traitement des syndromes douloureux chroniques Expired FR2521007B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU82384A HU185691B (en) 1982-02-09 1982-02-09 Process for preparing a new analgetic pharmaceutical composition

Publications (2)

Publication Number Publication Date
FR2521007A1 FR2521007A1 (fr) 1983-08-12
FR2521007B1 true FR2521007B1 (fr) 1986-05-02

Family

ID=10949360

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8301852A Expired FR2521007B1 (fr) 1982-02-09 1983-02-07 Matiere intermediaire pour inophorese et solution de contact pour le traitement des syndromes douloureux chroniques

Country Status (9)

Country Link
US (1) US4602909A (fr)
JP (1) JPS58198420A (fr)
BE (1) BE895850A (fr)
CH (1) CH660968A5 (fr)
DE (1) DE3304246A1 (fr)
FR (1) FR2521007B1 (fr)
GB (1) GB2116037B (fr)
HU (1) HU185691B (fr)
NL (1) NL8300444A (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU185691B (en) * 1982-02-09 1985-03-28 Richter Gedeon Vegyeszet Process for preparing a new analgetic pharmaceutical composition
US5135477A (en) * 1984-10-29 1992-08-04 Medtronic, Inc. Iontophoretic drug delivery
US4752285B1 (en) * 1986-03-19 1995-08-22 Univ Utah Res Found Methods and apparatus for iontophoresis application of medicaments
US4915685A (en) * 1986-03-19 1990-04-10 Petelenz Tomasz J Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange
US4886489A (en) * 1986-03-19 1989-12-12 Jacobsen Stephen C Flow-through methods and apparatus for iontophoresis application of medicaments at a controlled pH
US4731049A (en) * 1987-01-30 1988-03-15 Ionics, Incorporated Cell for electrically controlled transdermal drug delivery
US5362307A (en) * 1989-01-24 1994-11-08 The Regents Of The University Of California Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance
JP2907342B2 (ja) * 1988-01-29 1999-06-21 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア イオン滲透非侵襲的サンプリングまたは送出装置
US5023085A (en) * 1989-11-29 1991-06-11 Pfizer Inc. Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
US5084008A (en) * 1989-12-22 1992-01-28 Medtronic, Inc. Iontophoresis electrode
US6004309A (en) * 1990-03-30 1999-12-21 Alza Corporation Method and apparatus for controlled environment electrotransport
US5125894A (en) * 1990-03-30 1992-06-30 Alza Corporation Method and apparatus for controlled environment electrotransport
US5087241A (en) * 1990-07-24 1992-02-11 Empi, Inc. Iontophoresis electrode with reservoir and injection site
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5352683A (en) * 1993-03-05 1994-10-04 Virginia Commonwealth University Medical College Of Virginia Method for the treatment of chronic pain
US5885241A (en) * 1997-05-29 1999-03-23 Orton; Kevin R. Treatment with an electrically-activated substance
US6920884B2 (en) * 1997-05-29 2005-07-26 Kevin Orton Method of providing cosmetic/medical therapy
UA78672C2 (en) 1999-04-09 2007-04-25 Kevin R Orton Method for preparation and use of conductive medicinal substance (variants)
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
US10300031B2 (en) * 2007-08-06 2019-05-28 Trinity Laboratories Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE603705C (de) * 1931-06-18 1934-10-08 Desider Deutsch Dr Elektrode zur Einfuehrung von Heilmitteln in den Koerper mittels Iontophorese
US3163166A (en) * 1961-04-28 1964-12-29 Colgate Palmolive Co Iontophoresis apparatus
US3734097A (en) * 1969-04-01 1973-05-22 Alza Corp Therapeutic adhesive tape
US3677268A (en) * 1969-11-28 1972-07-18 Sherwood Medical Ind Inc Iontophoresis electrode
US3749784A (en) * 1972-05-03 1973-07-31 Lilly Co Eli Psoriasis treatment
US4029663A (en) * 1975-07-10 1977-06-14 Eli Lilly And Company Dimeric anhydro-vinca derivatives
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4115388A (en) * 1977-03-30 1978-09-19 Eli Lilly And Company 3'-Oxygenated derivatives of 4'-deoxy VLB "A" and "B" and related 1-formyl compounds
HU180924B (en) * 1977-05-20 1983-05-30 Richter Gedeon Vegyeszet Process for producing leurosine-type alkaloides
GB2012260B (en) * 1977-11-07 1982-11-03 Lilly Co Eli 4-desacetoxy 4 hydroxyindole dihydroindoles pharmaceutical formulations containing them and their use as antimitotic agents
HU185691B (en) * 1982-02-09 1985-03-28 Richter Gedeon Vegyeszet Process for preparing a new analgetic pharmaceutical composition

Also Published As

Publication number Publication date
GB8303382D0 (en) 1983-03-16
JPH0414081B2 (fr) 1992-03-11
DE3304246A1 (de) 1983-08-18
DE3304246C2 (fr) 1991-03-07
JPS58198420A (ja) 1983-11-18
US4602909A (en) 1986-07-29
GB2116037A (en) 1983-09-21
BE895850A (fr) 1983-08-08
GB2116037B (en) 1985-10-09
HU185691B (en) 1985-03-28
CH660968A5 (de) 1987-06-30
NL8300444A (nl) 1983-09-01
FR2521007A1 (fr) 1983-08-12

Similar Documents

Publication Publication Date Title
FR2521007B1 (fr) Matiere intermediaire pour inophorese et solution de contact pour le traitement des syndromes douloureux chroniques
RO87533A (fr) Procede pour la preparation des n-(bicycliqueheterocyclil)-4-pyperidinamines
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
PL206130A1 (pl) Urzadzenie do leczenia skrzywien kregoslupa
IL66931A (en) Process and device for the treatment of non conducting metal bonded hard materials
FR2577111B1 (fr) Machine pour le traitement des poireaux
BR8306378A (pt) Electrode material and process or manufacture
IT1152557B (it) Dispositivo geometrico del genere comunemente detto puzzle
RO83301A (fr) Procede pour la preparation des peptides
DE3364266D1 (en) Device for the wet treatment of photosensitive sheets
MA20655A1 (fr) Compositions pour le traitement de textiles
FR2536995B1 (fr) Composition pour le traitement de l'arthrite
DK318684A (da) Fluidumbehandlingsapparat
DE3362107D1 (en) Device for the heat treatment of fine-grained material
IL70561A0 (en) Treatment of cloth materials
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
FR2588756B1 (fr) Composition pour le traitement des cheveux
DE2964348D1 (en) Compositions for the treatment of chronic trypanosomiasis infections
FR2521975B1 (fr) Appareil pour le traitement anaerobie d'effluents residuaires
RO79428A2 (fr) Composition medicamenteuse pour le traitement des dermatoses
DE3269369D1 (en) Device for the treatment of continuous web material
PT77386A (en) Treatment of oxidic materials
FR2517203B1 (fr) Composition pour le traitement de l'acne
RO83870A2 (fr) Prepare hytoterapeutique pour le traitement de l'alveolite poste0traction
JPS5735063A (en) Liquid stream treatment of cloth

Legal Events

Date Code Title Description
ST Notification of lapse